Analysis of the impact of national centralized volume-based procurement drug policy on the market dynamics of tuberculosis drugs
Jian Yang, Xiaoyi Yu, Yifan Yao, Weili Zhao, Ying Chen, Zhebin Wang, Ming Xu · 2026
Read Analysis of the impact of national centralized volume-based procurement drug policy on the market dynamics of tuberculosis drugs by Jian Yang, Xiaoyi Yu, Yifan Yao, Weili Zhao, Ying Chen, Zhebin Wang, Ming Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13214198.txt.
Description
Jian Yang and co-authors studied how China bulk-buying drug policy moved the tuberculosis drug market, in a 2026 paper. The policy pools public demand and trades set volumes for low bids. Its effect on TB drug prices, spending, and market shape was unmeasured. The team used monthly hospital purchase data from 2015 to 2022.
Six TB drugs in the buying rounds formed the test group. Nine related drugs outside the rounds served as controls. An interrupted time series split results by hospital type. The study tracks three full buying cycles. Results can tune a flagship cost-cutting policy.
Catalog record
| CREATOR | Jian Yang, Xiaoyi Yu, Yifan Yao, Weili Zhao, Ying Chen, Zhebin Wang, Ming Xu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 149 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |